We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$6.97B
AUM Growth
+$4.79B
Cap. Flow
+$6.91B
Cap. Flow %
99.25%
Top 10 Hldgs %
36.51%
Holding
4,400
New
1,371
Increased
1,984
Reduced
143
Closed
794

Sector Composition

Rank Sector Weight
1 Technology 13.48%
2 Financials 8.05%
3 Industrials 7.03%
4 Consumer Discretionary 6.62%
5 Healthcare 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IOVA icon
3026
Iovance Biotherapeutics
IOVA
$2.68B
$2.78K ﹤0.01%
+1,282
New +$3.03K
KMTS
3027
Kestra Medical Technologies
KMTS
$1.51B
$2.78K ﹤0.01%
+117
New +$2.09K
NDLS icon
3028
Noodles & Co
NDLS
$107M
$2.76K ﹤0.01%
544
+272
+100% +$1.7K
APPS icon
3029
Digital Turbine
APPS
$1.7B
$2.75K ﹤0.01%
+430
New +$2.13K
TARS icon
3030
Tarsus Pharmaceuticals
TARS
$2.86B
$2.73K ﹤0.01%
+46
New +$2.27K
SGHT icon
3031
Sight Sciences
SGHT
$405M
$2.71K ﹤0.01%
+788
New +$2.93K
SION
3032
Sionna Therapeutics
SION
$2.3B
$2.71K ﹤0.01%
+92
New +$2K
CCU icon
3033
Compañía de Cervecerías Unidas
CCU
$2.23B
$2.7K ﹤0.01%
223
+133
+148% +$1.63K
GRND icon
3034
Grindr
GRND
$2.93B
$2.69K ﹤0.01%
+179
New +$3.14K
ABAT icon
3035
American Battery Technology Co
ABAT
$349M
$2.69K ﹤0.01%
+553
New +$1.45K
ADCT icon
3036
ADC Therapeutics
ADCT
$144M
$2.69K ﹤0.01%
+672
New +$2.12K
FSM icon
3037
Fortuna Silver Mines
FSM
$3.02B
$2.69K ﹤0.01%
300
CGAU
3038
Centerra Gold
CGAU
$4.13B
$2.68K ﹤0.01%
250
NC icon
3039
NACCO Industries
NC
$325M
$2.66K ﹤0.01%
+63
New +$2.5K
MLNK
3040
DELISTED
MeridianLink
MLNK
$2.65K ﹤0.01%
+133
New +$2.44K
PDLB icon
3041
Ponce Financial Group
PDLB
$483M
$2.63K ﹤0.01%
+179
New +$2.59K
SAIL
3042
SailPoint Inc
SAIL
$10.3B
$2.63K ﹤0.01%
+119
New +$2.49K
GRDN
3043
Guardian Pharmacy Services
GRDN
$2.84B
$2.62K ﹤0.01%
+100
New +$2.38K
REAX icon
3044
Real Brokerage
REAX
$469M
$2.62K ﹤0.01%
+626
New +$2.83K
VHI icon
3045
Valhi
VHI
$439M
$2.6K ﹤0.01%
+165
New +$2.76K
AURA icon
3046
Aura Biosciences
AURA
$806M
$2.6K ﹤0.01%
420
+125
+42% +$817
AGEN
3047
Agenus
AGEN
$301M
$2.57K ﹤0.01%
+667
New +$3.34K
LENZ
3048
LENZ Therapeutics
LENZ
$170M
$2.56K ﹤0.01%
+55
New +$2.02K
MCHB
3049
Mechanics Bancorp
MCHB
$3.68B
$2.56K ﹤0.01%
+192
New +$2.55K
ZBIO
3050
Zenas BioPharma
ZBIO
$2.01B
$2.55K ﹤0.01%
+115
New +$1.87K

Similar funds

Arax Advisory Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Arax Advisory Partners held 4,400 positions worth $6.97B, up 220% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Arax Advisory Partners deployed $6.91B of net new capital in Q3 2025, opening 1,371 new positions and adding to 1,984 existing holdings. Its largest new stake was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 6.5% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Axon Enterprise, an estimated $58.1M trimmed.

  • Arax Advisory Partners's largest Q3 2025 buy was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
  • Arax Advisory Partners added most to iShares S&P 100 ETF in Q3 2025, an estimated $2.43B increase.
  • Arax Advisory Partners's biggest Q3 2025 reduction was Axon Enterprise, cutting an estimated $58.1M.
  • Arax Advisory Partners fully exited Vanguard Morningstar Growth ETF in Q3 2025, selling an estimated $91.2M.
  • Arax Advisory Partners's ten largest holdings make up 37% of its $6.97B portfolio in Q3 2025.
  • Arax Advisory Partners opened 1,371 new positions and closed 794 in Q3 2025.
  • Arax Advisory Partners's portfolio value rose 220% quarter-over-quarter to $6.97B.

Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.